| pubmed-article:44907 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:44907 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:44907 | lifeskim:mentions | umls-concept:C0271429 | lld:lifeskim |
| pubmed-article:44907 | lifeskim:mentions | umls-concept:C0002645 | lld:lifeskim |
| pubmed-article:44907 | lifeskim:mentions | umls-concept:C0007537 | lld:lifeskim |
| pubmed-article:44907 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:44907 | pubmed:dateCreated | 1980-9-28 | lld:pubmed |
| pubmed-article:44907 | pubmed:abstractText | Twenty-eight patients with acute otitis media were treated in a random double blind manner with either amoxycillin or cefaclor. The predominant organisms isolated were H. influenzae and S. pneumoniae. All patients responded satisfactorily except one, treated with cefaclor, whose compliance with the regimen was very doubtful. One instance of mild elevation of SGOT and one case of mild erythematous rash occurred in each treatment group. In this limited study, cefaclor appeared comparable to amoxycillin in the treatment of acute otitis media. | lld:pubmed |
| pubmed-article:44907 | pubmed:language | eng | lld:pubmed |
| pubmed-article:44907 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:44907 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:44907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:44907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:44907 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:44907 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:44907 | pubmed:issn | 0032-5473 | lld:pubmed |
| pubmed-article:44907 | pubmed:author | pubmed-author:JacobsonJ AJA | lld:pubmed |
| pubmed-article:44907 | pubmed:author | pubmed-author:MatsenJ MJM | lld:pubmed |
| pubmed-article:44907 | pubmed:author | pubmed-author:ParkinJ LJL | lld:pubmed |
| pubmed-article:44907 | pubmed:author | pubmed-author:MetcalfT JTJ | lld:pubmed |
| pubmed-article:44907 | pubmed:author | pubmed-author:WenerstromL... | lld:pubmed |
| pubmed-article:44907 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:44907 | pubmed:volume | 55 Suppl 4 | lld:pubmed |
| pubmed-article:44907 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:44907 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:44907 | pubmed:pagination | 39-41 | lld:pubmed |
| pubmed-article:44907 | pubmed:dateRevised | 2009-10-22 | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Hu... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-In... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ot... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ch... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-St... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ch... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Fe... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ma... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ac... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ha... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Cl... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Do... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ce... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Am... | lld:pubmed |
| pubmed-article:44907 | pubmed:meshHeading | pubmed-meshheading:44907-Ce... | lld:pubmed |
| pubmed-article:44907 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:44907 | pubmed:articleTitle | Evaluation of cefaclor and amoxycillin in the treatment of acute otitis media. | lld:pubmed |
| pubmed-article:44907 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:44907 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:44907 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:44907 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:44907 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
